Table 2.
Additive | Type | Material | Gap size | Research time | Application | Ref. |
---|---|---|---|---|---|---|
Schwann cell | Cell | Silk–gold nanocomposite | 10 mm | 18 months | Enhancing myelination of the regenerated nerves | [100] |
Neural crest stem cell | Cell | Polycaprolactone nanofiber | 15 mm | 6/12 weeks | Promoting regeneration across large nerve gaps | [104] |
MSC | Cell | EPO-loaded Chitosan | 5 mm | 4/8 weeks | Accelerating nerve healing process | [103] |
ASC | Cell | Cryopolymerized gelatin methacryloyl |
10 mm | 4/8/16 weeks | Providing a conducive environment for nerve recovery | [46] |
OEC | Cell | Collagen–chitosan | 15 mm | 12 weeks | Promoting axonal regeneration and functional recovery |
[101] |
CNTF/bFGF | Factor | Collagen | 35 mm in minipig | 6 months | Repairing 35 mm gap in minipigs | [112] |
NGF | Factor | PCLA/silk fibroin | 15 mm | 12 weeks | Significant improvements in promoting and guiding neurite outgrowth | [113] |
GDNF | Factor | GDNF/PCL | 5 cm | 1 year | Increasing nerve conduction velocity and average area occupied by individual Schwann cells | [114] |
Platelet | Cytoplasm | GelMA/PEGDA | 10 mm | 12 weeks | Promoting hydrogel conduits in peripheral nerve repair | [56] |
Melatonin | Drug | PCL | 15 mm | 12 weeks | Improving recovery efficiency by inhibiting oxidative stress and inflammation | [117] |
XMU-MP-1 | Drug | GelMA | 10 mm | 3 months | Promoting the proliferation, migration and neurotrophic factors secretion of Schwann cells | [45] |
PSA/HNK-1 | Drug | Polyethylene | 5 mm | 8/15 weeks | Increasing the ratio of myelinated axons/improvements in myelination | [120] |
RGFP966 | Drug | GelMA | 10 mm | 3 months | Efficiently bridging a 10-mm gap of rat sciatic nerve by promoting remyelination of axons | [118] |